- Home
- KYMR vs XPEV Comparison
KYMR vs XPEV Comparison
Compare KYMR & XPEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | XPEV |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 12.5B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | KYMR | XPEV |
|---|---|---|
| Price | $109.69 | $9.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 5 |
| Target Price | ★ $107.72 | $23.08 |
| AVG Volume (30 Days) | 597.5K | ★ 5.8M |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | $25.76 |
| Revenue Next Year | $8.17 | $25.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $54.38 | $9.44 |
| 52 Week High | $130.05 | $28.20 |
Technical Indicators
Market Signals| Indicator | KYMR | XPEV |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 26.47 |
| Support Level | $76.40 | N/A |
| Resistance Level | $120.37 | $10.84 |
| Average True Range (ATR) | 4.55 | 0.22 |
| MACD | -0.98 | -0.03 |
| Stochastic Oscillator | 3.03 | 2.14 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.